Skip to main content
SpringerLink
Log in

Multiple sclerosis as a polygenic disease: An update

  • Reviews and Theoretical Articles
  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. The observed type of heredity associated with MS is characteristic of polygenic diseases, which arises from a joint contribution of a number of independently acting or interacting polymorphic genes. Recently to identify the genes responsible for genetic predisposition to MS two main approaches have been applied: (1) analysis of association of individual “candidate genes” with the disease and (2) analysis of the wide spectrum of chromosomal loci (whole genome screen) linkage with the disease in families with several MS patients. In the last two years, a new method, which borrowed the best approaches of the previous studies, genome-wide association screening (GWAS), which is based on the modern high-throughput DNA analysis, has been developed. This review describes replicated (validated) results for individual genes and DNA loci located on the majority of chromosomes obtained using these three strategies as well as data on association of MS with allelic combinations of various genes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Infante-Duarte, C., Waiczies, S., Wuerfel, J., and Zipp, F., New Developments in Understanding and Treating Neuroinflammation, J. Mol. Med., 2008, vol. 86, pp. 975–985.

    Article  CAS  PubMed  Google Scholar 

  2. Sobocki, P., Pugliatti, M., Lauer, K., and Kobeltz, G., Estimation of the Cost of MS in Europe: Extrapolations from a Multinational Cost Study, Mult. Scler., 2007, vol. 13, pp. 1054–1064.

    Article  CAS  PubMed  Google Scholar 

  3. Gusev, E.I., Boiko, A.N., Zavalishin, I.A., and Bykova, O.V., Contemporary Epidemiology of Multiple Sclerosis, in Rasseyannyi skleroz i drugie demieliniziruyushchie zabolevaniya (Multiple Sclerosis and Other Demyelinating Disorders), Moscow: Miklosh, 2004, pp. 8–29.

    Google Scholar 

  4. Compston, D.A.S. and Sadovnick, A.D., Epidemiology and Genetics of Multiple Sclerosis, Curr. Opin. Neurol. Neurosurg., 1992, vol. 5, pp. 175–181.

    CAS  PubMed  Google Scholar 

  5. Zhang, H., Zhao, H., and Merikangas, K., Strategies to Identify Genes for Complex Diseases, Ann. Med., 1997, vol. 29, pp. 493–498.

    Article  CAS  PubMed  Google Scholar 

  6. Farral, M., Mapping Genetic Susceptibility to Multiple Sclerosis, Lancet, 1996, vol. 348, pp. 1674–1675.

    Article  Google Scholar 

  7. Sadovnick, A.D., Ebers, G.C., Dyment, D.A., and Risch, N.J., The Canadian Collaborative Study Group. Evidence for Genetic Basis of Multiple Sclerosis, Lancet, 1996, vol. 347, pp. 1728–1730.

    Article  CAS  PubMed  Google Scholar 

  8. Robertson, N.P., Fraser, M., Deans, J., et al., AgeAdjusted Recurrence Risks for Relatives of Patients with Multiple Sclerosis, Brain, 1996, vol. 119, pp. 449–455.

    Article  PubMed  Google Scholar 

  9. Bomprezzi, R., Kovanen, P.E., and Martin, R., New Approaches to Investigating Heterogeneity in Complex Traits, J. Med. Genet., 2003, vol. 40, pp. 553–559.

    Article  CAS  PubMed  Google Scholar 

  10. Dyment, D.A., Yee, I.M., Ebers, G.C., and Sadovnick, A.D., The Canadian Collaborative Study Group. Multiple Sclerosis in Stepsiblings: Recurrence Risk and Ascertainment, J. Neurol. Neurosurg. Psychiatry, 2006, vol. 77, pp. 258–259.

    Article  CAS  PubMed  Google Scholar 

  11. Ebers, G., Prognostic Factors for Multiple Sclerosis: The Importance of Natural History Studies, J. Neurol., 2005, vol. 252, suppl., pp. 15–20.

    Google Scholar 

  12. Oksenberg, R., Baranzini, S.E., Sawcer, S., and Hauser, S.L., The Genetics of Multiple Sclerosis: SNPs to Pathways to Pathogenesis, Nat. Rev. Genet., 2008, vol. 9, pp. 516–526.

    Article  CAS  PubMed  Google Scholar 

  13. Thomson, G., Mapping Disease Genes: Family-Based Association Studies, Am. J. Hum. Genet., 1995, vol. 57, pp. 487–498.

    CAS  PubMed  Google Scholar 

  14. Sudomoina, M.A. and Favorova, O.O., A Search for Susceptibility Genes in Multiple Sclerosis, Mol. Biol. (Moscow), 2000, vol. 34, pp. 654–670.

    Article  CAS  Google Scholar 

  15. Herrera, B.M. and Ebers, G.C., Progress in Deciphering the Genetics of Multiple Sclerosis, Curr. Opin. Neurol., 2003, vol. 16, pp. 253–258.

    Article  CAS  PubMed  Google Scholar 

  16. Svejgaard, A., The Immunogenetics of Multiple Sclerosis, Immunogenetics, 2008, vol. 60, pp. 275–286.

    Article  CAS  PubMed  Google Scholar 

  17. Olsson, T. and Hillert, J., The Genetics of Multiple Sclerosis and Its Experimental Models, Curr. Opin. Neurol., 2008, vol. 21, no. 3, pp. 255–260.

    Article  PubMed  Google Scholar 

  18. Haines, J.L., Terwedow, H.A., Burgess, K., et al., Linkage of the MHC to Familial Multiple Sclerosis Suggests Genetic Heterogeneity, Hum. Mol. Genet., 1998, vol. 7, pp. 1229–1234.

    Article  CAS  PubMed  Google Scholar 

  19. Dai, K.Z., Harbo, H.F., Celius, E.G., et al., The T Cell Regulator Gene SH2D2A Contributes to the Genetic Susceptibility of Multiple Sclerosis, Genes Immun., 2001, vol. 2, no. 5, pp. 263–268.

    Article  CAS  PubMed  Google Scholar 

  20. Lorentzen, A.R., Smestad, C., Lie, B.A., et al., The SH2D2A Gene and Susceptibility to Multiple Sclerosis, J. Neuroimmunol., 2008, vol. 197, no. 2, pp. 152–158.

    Article  CAS  PubMed  Google Scholar 

  21. Zayas, M.D., Lucas, M., Solano, F., et al., Association of a CA Repeat Polymorphism Upstream of the Fas Ligand Gene with Multiple Sclerosis, J. Neuroimmunol., 2001, vol. 116, pp. 238–241.

    Article  CAS  PubMed  Google Scholar 

  22. Lucas, M., Zayas, M.D., De Costa, A.F., et al., A Study of Promoter and Intronic Markers of ApoI/Fas Gene and the Interaction with Fas Ligand in Relapsing Multiple Sclerosis, Eur. Neurol., 2004, vol. 52, pp. 12–17.

    Article  CAS  PubMed  Google Scholar 

  23. Schwinzer, R., Witte, T., Hundrieser, J., et al., Enhanced Frequency of a PTPRC (CD45) Exon A Mutation (77C G) in Systemic Sclerosis, Genes Immun., 2003, vol. 4, pp. 168–169.

    Article  CAS  PubMed  Google Scholar 

  24. Ballerini, C., Rosati, E., Salvetti, M., et al., Protein Tyrosine Phosphatase Receptor-Type C Exon 4 Gene Mutation Distribution in an Italian Multiple Sclerosis Population, Neurosci. Lett., 2002, vol. 328, pp. 325–327.

    Article  CAS  PubMed  Google Scholar 

  25. Martinez Doncel, A., Rubio, A., Arroyo, R., et al., Interleukin-10 Polymorphisms in Spanish Multiple Sclerosis Patients, J. Neuroimmunol., 2002, vol. 131, pp. 168–172.

    Article  CAS  PubMed  Google Scholar 

  26. Mihailova, S., Ivanova, M., Mihaylova, A., et al., Proand Anti-Inflammatory Cytokine Gene Polymorphism Profiles in Bulgarian Multiple Sclerosis Patients, J. Neuroimmunol., 2005, vol. 168, pp. 138–143.

    Article  CAS  PubMed  Google Scholar 

  27. de la Concha, E.G., Arroyo, R., Crusius, J.B., et al., Combined Effect of HLA-DRB1*1501 and Interleukin-1 Receptor Antagonist Gene Allele 2 in Susceptibility to Relapsing/Remitting Multiple Sclerosis, J. Neuroimmunol., 1997, vol. 80, pp. 172–178.

    Article  PubMed  Google Scholar 

  28. Dincic’, E., Zivkovic’, M., Stankovic’, A., et al., Association of Polymorphisms in CTLA-4, IL-1ra and IL1beta Genes with Multiple Sclerosis in Serbian Population, J. Neuroimmunol., 2006, vol. 177, pp. 146–50.

    Article  CAS  Google Scholar 

  29. Harbo, H.F., Celius, E.G., Vartdal, F., and Spurkland, A., CTLA4 Promoter and Exon 1 Dimorphisms in Multiple Sclerosis, Tissue Antigens, 1999, vol. 53, pp. 106–110.

    Article  CAS  PubMed  Google Scholar 

  30. Ligers, A., Xu, C., Saarinen, S., et al., The CTLA-4 Gene Is Associated with Multiple Sclerosis, J. Neuroimmunol., 1999, vol. 97, pp. 182–190.

    Article  CAS  PubMed  Google Scholar 

  31. Kantarci, O.H., Hebrink, D.D., Achenbach, S.J., et al., CTLA4 Is Associated with Susceptibility to Multiple Sclerosis, J. Neuroimmunol., 2003, vol. 134, pp. 133–141.

    Article  CAS  PubMed  Google Scholar 

  32. Niino, M., Kikuchi, S., Fukazawa, T., et al., Genetic Polymorphisms of Osteopontin in Association with Multiple Sclerosis in Japanese Patients, J. Neuroimmunol., 2003, vol. 136, pp. 125–129.

    Article  CAS  PubMed  Google Scholar 

  33. Chiocchetti, A., Comi, C., Indelicato, M., et al., Osteopontin Gene Haplotypes Correlate with Multiple Sclerosis Development and Progression, J. Neuroimmunol., 2005, vol. 163, pp. 172–178.

    Article  CAS  PubMed  Google Scholar 

  34. Epplen, C., Buitkamp, J., Rumpf, H., et al., Immunoprinting Reveals Different Genetic Bases for (Auto)Immuno Diseases, Electrophoresis, 1995, vol. 16, pp. 1693–1697.

    Article  CAS  PubMed  Google Scholar 

  35. Matesanz, F., Fedetz, M., Collado-Romero, M., et al., Allelic Expression and Interleukin-2 Polymorphisms in Multiple Sclerosis, J. Neuroimmunol., 2001, vol. 119, pp. 101–105.

    Article  CAS  PubMed  Google Scholar 

  36. Zhang, Z., Duvefelt, K., Svensson, F., et al., Two Genes Encoding Immune-Regulatory Molecules (LAG3 and IL7R) Confer Susceptibility to Multiple Sclerosis, Genes Immun., 2005, vol. 6, pp. 145–152.

    Article  CAS  PubMed  Google Scholar 

  37. Booth, D.R., Arthur, A.T., Teutsch, S.M., et al., The Southern MS Genetics Consortium: Gene Expression and Genotyping Studies Implicate the Interleukin 7 Receptor in the Pathogenesis of Primary Progressive Multiple Sclerosis, J. Mol. Med., 2005, vol. 83, pp. 822–830.

    Article  CAS  PubMed  Google Scholar 

  38. Lundmark, F., Duvefelt, K., Iacobaeus, E., et al., Variation in Interleukin 7 Receptor Alpha Chain (IL7R) Influences Risk of Multiple Sclerosis, Nat. Genet., 2007, vol. 39, pp. 1108–1113.

    Article  CAS  PubMed  Google Scholar 

  39. Gregory, S.G., Schmidt, S., Seth, P., et al., Multiple Sclerosis Genetics Group: Interleukin 7 Receptor Alpha Chain (IL7R) Shows Allelic and Functional Association with Multiple Sclerosis, Nat. Genet., 2007, vol. 39, pp. 1083–1091.

    Article  CAS  PubMed  Google Scholar 

  40. Weber, F., Fontaine, B., Cournu-Rebeix, I., et al., IL2RA and IL7RA Genes Confer Susceptibility for Multiple Sclerosis in Two Independent European Populations, Genes Immun., 2008, vol. 9, pp. 259–263.

    Article  CAS  PubMed  Google Scholar 

  41. Kantarci, O.H., Schaefer-Klein, J.L., Hebrink, D.D., et al., A Population-Based Study of IL4 Polymorphisms in Multiple Sclerosis, J. Neuroimmunol., 2003, vol. 137, pp. 134–139.

    Article  CAS  PubMed  Google Scholar 

  42. Urcelay, E., Santiago, J.L., Mas, A., et al., Role of Interleukin 4 in Spanish Multiple Sclerosis Patients, J. Neuroimmunol., 2005, vol. 168, pp. 164–167.

    Article  CAS  PubMed  Google Scholar 

  43. Sandberg-Wollheim, M., Ciusani, E., Salmaggi, A., and Pociot, F., An Evaluation of Tumor Necrosis Factor Microsatellite Alleles in Genetic Susceptibility to Multiple Sclerosis, Mult. Scler., 1995, vol. 1, pp. 181–185.

    CAS  PubMed  Google Scholar 

  44. Boiko, A.N., Guseva, M.E., Guseva, M.R., et al., Clinico-Immunogenetic Characteristics of Multiple Sclerosis with Optic Neuritis in Children, J. Neurovirol., 2000, suppl. 2, pp. 152–155.

  45. Favorova, O.O., Favorov, A.V., Boiko, A.N., et al., Three Allele Combinations Associated with Multiple Sclerosis, BMC Med. Genet., 2006, vol. 7, pp. 63–70.

    Article  PubMed  CAS  Google Scholar 

  46. de Jong, B.A., Huizinga, T.W., Zanelli, E., et al., Evidence for Additional Genetic Risk Indicators of Relapse-Onset MS within the HLA Region, Neurology, 2002, vol. 59, pp. 549–555.

    Article  PubMed  Google Scholar 

  47. Kirk, C.W., Droogan, A.G., Hawkins, S.A., et al., Tumor Necrosis Factor Microsatellites Show Association with Multiple Sclerosis, J. Neurol. Sci., 1997, vol. 147, pp. 21–25.

    Article  CAS  PubMed  Google Scholar 

  48. Fernandez-Arquero, M., Arroyo, R., Rubio, A., et al., Primary Association of a TNF Gene Polymorphism with Susceptibility to Multiple Sclerosis, Neurology, 1999, vol. 53, pp. 1361–1363.

    CAS  PubMed  Google Scholar 

  49. Martinez, A., Rubio, A., Urcelay, E., et al., TNF-376A Marks Susceptibility to MS in the Spanish Population: A Replication Study, Neurology, 2004, vol. 62, pp. 809–810.

    CAS  PubMed  Google Scholar 

  50. Mycko, M., Kowalski, W., Kwinkowski, M., et al., Multiple Sclerosis: The Frequency of Allelic Forms of Tumor Necrosis Factor and Lymphotoxin-Alpha, J. Neuroimmunol., 1998, vol. 84, pp. 198–206.

    Article  CAS  PubMed  Google Scholar 

  51. Goris, A., Epplen, C., Fiten, P., et al., Analysis of an IFN-Gamma Gene (IFNG) Polymorphism in Multiple Sclerosis in Europe: Effect of Population Structure on Association with Disease, J. Interferon Cytokine Res., 1999, vol. 19, pp. 1037–1046.

    Article  CAS  PubMed  Google Scholar 

  52. Amirzargar, A., Khosravi, F., Dianat, S., et al., Profile of Cytokine Gene Polymorphisms in Iranian Multiple Sclerosis Patients, Mult. Scler., 2007, vol. 13, pp. 253–255.

    Article  CAS  PubMed  Google Scholar 

  53. Sarial, S., Shokrgozar, M.A., Amirzargar, A., et al., IL-1, IL-1R and TNFalpha Gene Polymorphisms in Iranian Patients with Multiple Sclerosis, Iran J. Allergy Asthma Immunol., 2008, vol. 7, pp. 37–40.

    CAS  PubMed  Google Scholar 

  54. Alekseenkov, A.D., Sudomoina, M.A., Boiko, A.N., et al., Two Single-Base Polymorphisms in the Human Tumor Necrosis Factor Locus of Multiple Sclerosis Patients from the Russian Population: NcoI-RFLP in the First Intron of the Human Lymphotoxin Gene Correlates with the Disease, Mol. Biol. (Moscow), 1999, vol. 33, pp. 190–196.

    CAS  Google Scholar 

  55. Fernandes Filho, J.A., Vedeler, C.A., Myhr, K.M., et al., TNF-Alpha and -Beta Gene Polymorphisms in Multiple Sclerosis: A Highly Significant Role for Determinants in the First Intron of the TNF-Beta Gene, Autoimmunity, 2002, vol. 35, pp. 377–380.

    Article  PubMed  Google Scholar 

  56. Hilton, A.A., Slavin, A.J., Hilton, D.J., and Bernard, C.C., Characterization of cDNA and Genomic Clones Encoding Human Myelin Oligodendrocyte Glycoprotein, J. Neurochem., 1995, vol. 65, pp. 309–318.

    CAS  PubMed  Google Scholar 

  57. D’Alfonso, S., Bolognesi, E., Guerini, F.R., et al., A Sequence Variation in the MOG Gene Is Involved in Multiple Sclerosis Susceptibility in Italy, Genes Immun., 2008, vol. 9, pp. 7–15.

    Article  PubMed  CAS  Google Scholar 

  58. Zhou, Q., Rammohan, K., Lin, S., et al., CD24 Is a Genetic Modifier for Risk and Progression of Multiple Sclerosis, Proc. Natl. Acad. Sci. USA, 2003, vol. 100, pp. 15041–15046.

    Article  CAS  PubMed  Google Scholar 

  59. Otaegui, D., Sáenz, A., Camaño, P., et al., CD24 V/V Is an Allele Associated with the Risk of Developing Multiple Sclerosis in the Spanish Population, Mult. Scler., 2006, vol. 12, pp. 511–514.

    Article  CAS  PubMed  Google Scholar 

  60. Niino, M., Kikuchi, S., Fukazawa, T., et al., Estrogen Receptor Gene Polymorphism in Japanese Patients with Multiple Sclerosis, J. Neurol. Sci., 2000, vol. 179, pp. 70–75.

    Article  CAS  PubMed  Google Scholar 

  61. Kikuchi, S., Fukazawa, T., Niino, M., et al., Estrogen Receptor Gene Polymorphism and Multiple Sclerosis in Japanese Patients: Interaction with HLADRB1*1501 and Disease Modulation, J. Neuroimmunol., 2002, vol. 128, pp. 77–81.

    Article  CAS  PubMed  Google Scholar 

  62. Mattila, K.M., Luomala, M., Lehtimäki, T., et al., Interaction between ESR1 and HLA-DR2 May Contribute to the Development of MS in Women, Neurology, 2001, vol. 56, pp. 1246–1247.

    CAS  PubMed  Google Scholar 

  63. Vandenbroeck, K., Fiten, P., Heggarty, S., et al., Chromosome 7q21-22 and Multiple Sclerosis: Evidence for a Genetic Susceptibility Effect in Vicinity to the Protachykinin-1 Gene, J. Neuroimmunol., 2002, vol. 125, pp. 141–148.

    Article  CAS  PubMed  Google Scholar 

  64. Cunningham, S., Patterson, C.C., McDonnell, G., et al., Haplotype Analysis of the Preprotachykinin-1 (TAC1) Gene in Multiple Sclerosis, Genes Immun., 2005, vol. 6, pp. 265–270.

    Article  CAS  PubMed  Google Scholar 

  65. Luomala, M., Elovaara, I., Ukkonen, M., et al., Plasminogen Activator Inhibitor 1 Gene and Risk of MS in Women, Neurology, 2000, vol. 54, pp. 1862–1864.

    CAS  PubMed  Google Scholar 

  66. Lovrecic’, L., Ristic’, S., Starcevic’-Cizmarevic’, N., et al., PAI and TPA Gene Polymorphisms in Multiple Sclerosis, Mult. Scler., 2008, vol. 14, pp. 243–247.

    Article  Google Scholar 

  67. Beall, S.S., Biddison, W.E., McFarlin, D.E., et al., Susceptibility for Multiple Sclerosis Is Determined, in Part, by Inheritance of a 175-kb Region of the TcR V Beta Chain Locus and HLA Class II Genes, J. Neuroimmunol., 1993, vol. 45, pp. 53–60.

    Article  CAS  PubMed  Google Scholar 

  68. Martínez-Naves, E., Victoria-Gutiérrez, M., Uria, D.F., and López-Larrea, C., The Germline Repertoire of T Cell Receptor Beta-Chain Genes in Multiple Sclerosis Patients from Spain, J. Neuroimmunol., 1993, vol. 47, pp. 9–13.

    Article  PubMed  Google Scholar 

  69. Buhler, M.M., Bennetts, B.H., Heard, R.N., and Stewart, G.J., T Cell Receptor Beta Chain Genotyping in Australian Relapsing-Remitting Multiple Sclerosis Patients, Mult. Scler., 2000, vol. 6, pp. 140–147.

    CAS  PubMed  Google Scholar 

  70. van Veen, T., Kalkers, N.F., Crusius, J.B., et al., The FAS-670 Polymorphism Influences Susceptibility to Multiple Sclerosis, J. Neuroimmunol., 2002, vol. 128, pp. 95–100.

    Article  PubMed  Google Scholar 

  71. Kantarci, O.H., Hebrink, D.D., Achenbach, S.J., et al., CD95 Polymorphisms Are Associated with Susceptibility to MS in Women: A Population-Based Study of CD95 and CD95L in MS, J. Neuroimmunol., 2004, vol. 146, pp. 162–170.

    Article  CAS  PubMed  Google Scholar 

  72. Matesanz, F., Caro-Maldonado, A., Fedetz, M., et al., IL2RA/CD25 Polymorphisms Contribute to Multiple Sclerosis Susceptibility, J. Neurol., 2007, vol. 254, pp. 682–684.

    Article  CAS  PubMed  Google Scholar 

  73. Vogler, S., Goedde, R., Miterski, B., et al., Association of a Common Polymorphism in the Promoter of UCP2 with Susceptibility to Multiple Sclerosis, J. Mol. Med., 2005, vol. 83, pp. 806–811.

    Article  CAS  PubMed  Google Scholar 

  74. Otaegui, D., Saenz, A., Ruiz-Martinez, J., et al., UCP2 and Mitochondrial Haplogroups as a Multiple Sclerosis Risk Factor, Mult. Scler., 2007, vol. 13, pp. 454–458.

    CAS  PubMed  Google Scholar 

  75. Fukazawa, T., Yabe, I., Kikuchi, S., et al., Association of Vitamin D Receptor Gene Polymorphism with Multiple Sclerosis in Japanese, J. Neurol. Sci., 1999, vol. 166, pp. 47–52.

    Article  CAS  PubMed  Google Scholar 

  76. Niino, M., Fukazawa, T., Yabe, I., et al., Vitamin D Receptor Gene Polymorphism in Multiple Sclerosis and the Association with HLA Class II Alleles, J. Neurol. Sci., 2000, vol. 177, pp. 65–71.

    Article  CAS  PubMed  Google Scholar 

  77. Partridge, J.M., Weatherby, S.J., Woolmore, J.A., et al., Susceptibility and Outcome in MS: Associations with Polymorphisms in Pigmentation-Related Genes, Neurology, 2004, vol. 62, pp. 2323–2325.

    CAS  PubMed  Google Scholar 

  78. Kantarci, O.H., Goris, A., Hebrink, D.D., et al., IFNG Polymorphisms Are Associated with Gender Differences in Susceptibility to Multiple Sclerosis, Genes Immun., 2005, vol. 6, pp. 153–161.

    Article  CAS  PubMed  Google Scholar 

  79. Rasmussen, H.B., Kelly, M.A., and Clausen, J., Genetic Susceptibility to Multiple Sclerosis: Detection of Polymorphic Nucleotides and an Intron in the 3’ Untranslated Region of the Major Histocompatibility Complex Class II Transactivator Gene, Hum. Immunol., 2001, vol. 62, pp. 371–377.

    Article  CAS  PubMed  Google Scholar 

  80. Swanberg, M., Lidman, O., Padyukov, L., et al., MHC2TA Is Associated with Differential MHC Molecule Expression and Susceptibility to Rheumatoid Arthritis, Multiple Sclerosis and Myocardial Infarction, Nat. Genet., 2005, vol. 37, pp. 486–494.

    Article  CAS  PubMed  Google Scholar 

  81. Suppiah, V., Goris, A., Alloza, I., et al., Polymorphisms in the Interleukin-4 and IL-4 Receptor Genes and Multiple Sclerosis: A Study in Spanish-Basque, Northern Irish and Belgian Populations, Int. J. Immunogenet., 2005, vol. 32, pp. 383–388.

    Article  CAS  PubMed  Google Scholar 

  82. Brassat, D., Motsinger, A.A., Caillier, S.J., et al., Multifactor Dimensionality Reduction Reveals GeneGene Interactions Associated with Multiple Sclerosis Susceptibility in African Americans, Genes Immun., 2006, vol. 7, pp. 310–315.

    Article  CAS  PubMed  Google Scholar 

  83. Gade-Andavolu, R. and Comings, D.E., MacMurray, J., et al., RANTES: A Genetic Risk Marker for Multiple Sclerosis, Mult. Scler., 2004, vol. 10, pp. 536–539.

    Article  CAS  PubMed  Google Scholar 

  84. Vyshkina, T., Shugart, Y.Y., Birnbaum, G., et al., Association of Haplotypes in the Beta-Chemokine Locus with Multiple Sclerosis, Eur. J. Hum. Genet., 2005, vol. 13, pp. 240–247.

    Article  CAS  PubMed  Google Scholar 

  85. Vyshkina, T. and Kalman, B., Analyses of a MS-Associated Haplotype Encompassing the CCL3 Gene, J. Neuroimmunol., 2006, vol. 176, pp. 216–218.

    Article  CAS  PubMed  Google Scholar 

  86. Tienary, P.J., Wikstrom, J., Sajantia, A., et al., Genetic Susceptibility to Multiple Sclerosis Linked to Myelin Basic Protein Gene, Lancet, 1992, vol. 340, pp. 987–991.

    Article  Google Scholar 

  87. Pihlaja, H., Rantamaki, T., Wikstrom, J., et al., Linkage Disequilibrium between the MBP Tetranucleotide Repeat and Multiple Sclerosis Is Restricted to a Geographically Defined Subpopulation in Finland, Genes Immun., 2003, vol. 4, pp. 138–146.

    Article  CAS  PubMed  Google Scholar 

  88. Ibsen, S.N. and Clausen, J., A Repetitive DNA Sequence 5′ to the Human Myelin Basic Protein Gene May Be Linked to MS in Danes, Acta Neurol. Scand., 1996, vol. 93, pp. 236–240.

    Article  CAS  PubMed  Google Scholar 

  89. Guerini, F.R., Ferrante, P., Losciale, L., et al., Myelin Basic Protein Gene Is Associated with MS in DR4and DR5-Positive Italians and Russians, Neurology, 2003, vol. 61, pp. 520–526.

    CAS  PubMed  Google Scholar 

  90. Mycko, M.P., Kwinkowski, M., Tronczynska, E., et al., Multiple Sclerosis: The Increased Frequency of the ICAM-1 Exon 6 Gene Point Mutation Genetic Type K469, Ann. Neurol., 1998, vol. 44, pp. 70–75.

    Article  CAS  PubMed  Google Scholar 

  91. Nejentsev, S., Laaksonen, M., Tienari, P.J., et al., Intercellular Adhesion Molecule-1 K469E Polymorphism: Study of Association with Multiple Sclerosis, Hum. Immunol., 2003, vol. 64, pp. 345–349.

    Article  CAS  PubMed  Google Scholar 

  92. Cournu-Rebeix, I., Génin, E., Lesca, G., et al., Intercellular Adhesion Molecule-1: A Protective Haplotype Against Multiple Sclerosis, Genes Immun., 2003, vol. 4, pp. 518–523.

    Article  CAS  PubMed  Google Scholar 

  93. Barcellos, L.F., Thomson, G., Carrington, M., et al., Chromosome 19 Single-Locus and Multilocus Haplotype Associations with Multiple Sclerosis: Evidence of a New Susceptibility Locus in Caucasian and Chinese Patients, JAMA, 1997, vol. 278, pp. 1282–1283.

    Article  Google Scholar 

  94. Schmidt, S., Barcellos, L.F., DeSombre, K., et al., Multiple Sclerosis Genetics Group: Association of Polymorphisms in the Apolipoprotein E Region with Susceptibility to and Progression of Multiple Sclerosis, Am. J. Hum. Genet., 2002, vol. 70, pp. 708–717.

    Article  CAS  PubMed  Google Scholar 

  95. Hogh, P., Oturai, A., Schreiber, K., et al., Apoliprotein E and Multiple Sclerosis: Impact of the Epsilon-4 Allele on Susceptibility, Clinical Type and Progression Rate, Mult. Scler., 2000, vol. 6, pp. 226–230.

    Article  CAS  PubMed  Google Scholar 

  96. Andreevskii, T.V., Sudomoina, M.A., Boiko, A.N., and Favorova, O.O., Genetics of Multiple Sclerosis, in Rasseyannyi skleroz i drugie demieliniziruyushchie zabolevaniya (Multiple Sclerosis and Other Demyelinating Disorders), Moscow: Miklosh, 2004, pp. 43–45.

    Google Scholar 

  97. Gomez-Lira, M., Liguori, M., Magnani, C., et al., CD45 and Multiple Sclerosis: The Exon 4 C77G Polymorphism (Additional Studies and Meta-Analysis) and New Markers, J. Neuroimmunol., 2003, vol. 140, pp. 216–221.

    Article  CAS  PubMed  Google Scholar 

  98. Dyment, D.A., Ebers, G.C., and Sadovnick, A.D., Genetics of Multiple Sclerosis, Lancet Neurol., 2004, vol. 3, pp. 104–110.

    Article  CAS  PubMed  Google Scholar 

  99. Fernald, G.H., Yeh, R.F., Hauser, S.L., et al., Mapping Gene Activity in Complex Disorders: Integration of Expression and Genomic Scans for Multiple Sclerosis, J. Neuroimmunol., 2005, vol. 167, pp. 157–169.

    Article  CAS  PubMed  Google Scholar 

  100. Wise, L.H., Lanchbury, J.S., and Lewis, C.M., MetaAnalysis of Genome Searches, Ann. Hum. Genet., 1999, vol. 63, pp. 263–272.

    Article  CAS  PubMed  Google Scholar 

  101. GAMES and the Transatlantic Multiple Sclerosis Genetics Cooperative, A Meta-Analysis of Whole Genome Linkage Screens in Multiple Sclerosis, J. Neuroimmunol., 2003, vol. 143, pp. 39–46.

  102. Abdeen, H., Heggarty, S., Hawkins, S.A., et al., Mapping Candidate Non-MHC Susceptibility Regions to Multiple Sclerosis, Genes Immun., 2006, vol. 7, pp. 494–502.

    Article  CAS  PubMed  Google Scholar 

  103. Sawcer, S., Ban, M., Maranian, M., et al., A HighDensity Screen for Linkage in Multiple Sclerosis, Am. J. Hum. Genet., 2005, vol. 77, pp. 454–467.

    Article  PubMed  Google Scholar 

  104. Risch, N.J., Searching for Genetic Determinants in the New Millennium, Nature, 2000, vol. 405, pp. 847–856.

    Article  CAS  PubMed  Google Scholar 

  105. International Multiple Sclerosis Genetics Consortium, Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study, N. Engl. J. Med., 2007, vol. 357, pp. 851–862.

  106. Wellcome Trust Case Control Consortium and Australo-Anglo-American Spondylitis Consortium (TASC), Association Scan of 14.500 Nonsynonymous SNPs in Four Diseases Identifies Autoimmunity Variants, Nature Genet., 2007, vol. 39, pp. 1329–1337.

  107. Rubio, J.P., Stankovich, J., Field, J., et al., Replication of KIAA0350, IL2RA, RPL5 and CD58 as Multiple Sclerosis Susceptibility Genes in Australians, Genes Immun., 2008, vol. 9, pp. 624–630.

    Article  CAS  PubMed  Google Scholar 

  108. Favorov, A.V., Andreewski, T.V., Sudomoina, M.A., et al., A Markov Chain Monte Carlo Technique for Identification of Combinations of Allelic Variants Underlying Complex Diseases in Humans, Genetics, 2005, vol. 171, pp. 2113–2121.

    Article  CAS  PubMed  Google Scholar 

  109. Motsinger, A.A., Brassat, D., Caillier, S.J., et al., Complex Gene-Gene Interactions in Multiple Sclerosis: A Multifactorial Approach Reveals Associations with Inflammatory Genes, Neurogenetics, 2007, vol. 8, pp. 11–20.

    Article  CAS  PubMed  Google Scholar 

  110. Epplen, C., Jäckel, S., Santos, E.J., et al., Genetic Predisposition to Multiple Sclerosis as Revealed by Immunoprinting, Neurology, 1997, vol. 41, pp. 341–352.

    CAS  Google Scholar 

  111. Green, A.J., Barcellos, L.F., Rimmler, J.B., et al., Sequence Variation in the Transforming Growth FactorBeta1 (TGFB1) Gene and Multiple Sclerosis Susceptibility, J. Neuroimmunol., 2001, vol. 116, pp. 116–124.

    Article  CAS  PubMed  Google Scholar 

  112. Favorova, O.O., Andreewski, T.V., Boiko, A.N., et al., The Chemokine Receptor CCR5 Deletion Mutation Is Associated with MS in HLA-DR4-Positive Russians, Neurology, 2002, vol. 59, pp. 1652–1655.

    CAS  PubMed  Google Scholar 

  113. Mirel, D.B., Barcellos, L.F., Wang, S.L., et al., Analysis of IL4R Haplotypes in Predisposition to Multiple Sclerosis, Genes Immun., 2004, vol. 5, pp. 138–141.

    Article  CAS  PubMed  Google Scholar 

  114. Alizadeh, M., Babron, M.C., Birebent, B., et al., Genetic Interaction of CTLA-4 with HLA-DR15 in Multiple Sclerosis Patients, Ann. Neurol., 2003, vol. 54, pp. 119–122.

    Article  CAS  PubMed  Google Scholar 

  115. Madsen, L.S., Andersson, E.C., Jansson, L., et al., A Humanized Model for Multiple Sclerosis Using HLADR2 and a Human T-Cell Receptor, Nat. Genet., 1999, vol. 23, pp. 343–347.

    Article  CAS  PubMed  Google Scholar 

  116. Gregersen, J.W., Kranc, K.R., Ke, X., et al., Functional Epistasis on a Common MHC Haplotype Associated with Multiple Sclerosis, Nature, 2006, vol. 443, pp. 574–577.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Russian State Medical University, Moscow, 117997, Russia

    O. O. Favorova, O. G. Kulakova & A. N. Boiko

Authors
  1. O. O. Favorova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. G. Kulakova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. N. Boiko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. O. Favorova.

Additional information

Original Russian Text © O.O. Favorova, O.G. Kulakova, A.N. Boiko, 2010, published in Genetika, 2010, Vol. 46, No. 3, pp. 302–313.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Favorova, O.O., Kulakova, O.G. & Boiko, A.N. Multiple sclerosis as a polygenic disease: An update. Russ J Genet 46, 265–275 (2010). https://doi.org/10.1134/S1022795410030026

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1022795410030026

Keywords

Search

Navigation